Dr. Thomas Michael Leventhal, MD

Dr. Leventhal practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Leventhal's NPI, 1275720898, was assigned on September 27, 2007. Dr. Leventhal graduated from Loyola University of Chicago, Stritch School of Medicine in 2007. Dr. Leventhal holds Minnesota license 51397.

Dr. Leventhal's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Leventhal's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Leventhal is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Leventhal to 2 more hospitals, 9 medical groups, 6 group practices and clinics, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leventhal practices, 12 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Leventhal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Leventhal's licenses on file in 2 states: Minnesota and Kansas.

CMS data shows 129 Medicare services from Dr. Leventhal across 5 procedure codes in 2024, for 119 Medicare patients. Medicare paid $6,973 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Dr. Leventhal in 2024. The largest group is 65 to 74, with 59 patients. 67% of them have high blood pressure, and 52% have chronic kidney disease. 31% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leventhal's median patient age at 58, with 45% women.

In 2024, Dr. Leventhal wrote 777 Medicare Part D claims for 133 patients. 89% of them were for generic drugs. CMS names the drug for 629 of them, across 17 drugs with 11 or more claims each, at $230,305 in total drug cost. In 2023, CMS named 621 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Leventhal for performance year 2024, reported as part of a group. Dr. Leventhal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leventhal as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Leventhal, published from 2013 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Liver Transplantation, Health Expenditures and Hepatic Encephalopathy. Dr. Leventhal has published most often in ACG Case Rep J. Dr. Leventhal's most frequent co-authors are Chimaobi Michael Anugwom, MBBS, Jonathan David Alpern and Nathan Charles Bahr, MD.

CMS Open Payments shows 5 general payments to Dr. Leventhal from 3 drug and device companies from 2018 to 2024. Speaker and faculty fees make up the largest share, 97% of the total. Cook Medical LLC paid the most, $1,896.

Dr. Leventhal graduated from Loyola University of Chicago, Stritch School of Medicine in 2007.